The favorable outcomes observed in the present study can be explained as Losartan-only and Losartan + Lisinopril combination treatments resulted in marked reductions in the levels of the pro-inflammatory cytokines IL-6 and TNF-α following infection by SARS-CoV-2. This evidence concerns the gene IL6 and infection.